Preclinical efficacy of growth hormone - releasing hormone antagonists for androgen - dependent and castration -
resistant human prostate cancer.
Not exact matches
Serendipitously, the antimicrobial peptide shows promise for protecting
humans from
cancer; it can inhibit the growth of
prostate and bladder
cancer cells, as well as multi-drug
resistant leukemic cells.
The researchers showed that cabazitaxel worked better than docetaxel in
human prostate cancer cells lines that were
resistant hormone treatment, both in terms of slowing
cancer - cell growth and in its ability to kill
cancer cells.